Toby A. Vaughn

Toby A. Vaughn has extensive experience in the pharmaceutical industry. Toby A. is currently the Vice President, Head of Clinical Operations at Jnana Therapeutics since May 2022. Prior to that, they served as the Vice President Clinical Operations at Sio Gene Therapies from August 2020 to June 2022.

Between 2016 and 2020, Toby held positions at Liquidia Technologies, including Vice President Clinical Development from January 2019 to August 2020 and Executive Director, Clinical Operations from July 2016 to January 2019.

Toby A. also worked at Exact Sciences as the Sr. Director, Clinical Operations from February 2014 to May 2016.

Before that, Toby worked at Warner Chilcott/Actavis as the Associate Director, Clinical Operations from November 2009 to February 2014, where they provided operational and implementation expertise to clinical development teams and managed and mentored Clinical Study Managers.

Their earlier experience includes roles at P&G Pharmaceuticals from July 2006 to October 2009 as KOL Management and at Procter & Gamble Pharmaceuticals from January 1999 to June 2009 as Section Head, Cardiac Clinical Operations.

Toby A. Vaughn obtained a Bachelor of Science degree in Biology from Xavier University between 1977 and 1981. Afterward, Toby pursued higher education and earned a Master of Science degree in Clinical Pharmacology from The Ohio State University College of Medicine from 1989 to 1992. Additionally, there is some information indicating that Toby may have attended Xavier University again at some point, but the years and specific details are unknown.